0.69 (-%)
As of Nov 20, 2024
Source:
Hepion Pharmaceuticals, Inc. is a biopharmaceutical company headquartered in Edison, New Jersey, focused primarily on the development of drug therapy for treatment of chronic fibrosis related diseases. The main therapeutic approach specifically targets the disease mechanism related to fibrosis as well as, inflammation and shows potential for the treatment of non-alcoholic steatohepatitis , hepatocellular carcinoma , viral hepatitis, and other fibrotic diseases.
Country | United States |
Headquarters | edison, new jersey |
Phone Number | 732-902-4000 |
Industry | manufacturing |
CEO | John Cavan |
Website | www.Hepion.com |